Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Aug 2015 for LISATA THERAPEUTICS, INC., €15k.
Insider track record
Disclosed buys
4
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
4
Positive at T+90
25%
Median T+90
-19.0%
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -57.1%Entry US$210.00 · Close at T+365 US$90.15
- -59.0%Entry US$225.00 · Close at T+365 US$92.25
- -15.9%Entry US$35.87 · Close at T+365 US$30.15
- +136.7%Entry US$13.20 · Close at T+365 US$31.24
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert S. Vaters: trading record in brief
Filings by Robert S. Vaters span 3 companies, the busiest being Lisata Therapeutics, Inc., Orthofix Medical Inc. and Inamed Corp. Between 17 March 2006 and 12 August 2015, the trades on record add up to 11 filings.
Every open-market trade on record is a purchase: 4 purchases worth €268k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants. 2015 to date brings 2 purchases and no sales.
The median purchase comes to €81k. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 25% of cases, with a median move of -19.0%. They describe history only and say nothing certain about the share price ahead.
On 13 August 2015 came the latest disclosure, an open-market purchase for €15k in Lisata Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert S. Vaters
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
12,385 shares@ US$1.35Common Stock, par value $0.001 per shareSEC:0001144204-15-048795:0
Canonical exit: 10 Nov 2015 (T+90)
81,000 shares@ US$1.24Common Stock, par value $0.001 per shareSEC:0001144204-15-048105:0
Canonical exit: 9 Nov 2015 (T+90)
60,000 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-15-035633:0
137,028 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-15-003140:0
61,663 shares@ US$3.48Common Stock, par value $0.001 per shareSEC:0001144204-15-003140:1
3,000 shares@ US$35.97Common StockSEC:0000884624-13-000007:0
Canonical exit: 28 May 2013 (T+90)
40,000 shares0Common StockSEC:0000884624-12-000010:0
17,000 shares0Common StockSEC:0001439260-11-000003:0
9,100 shares@ US$10.94Common StockSEC:0001222958-08-000004:0
Canonical exit: 1 Mar 2009 (T+90)
11,128 sharesCommon StockSEC:0001104659-06-019561:0
7,522 sharesCommon StockSEC:0001244236-06-000009:0
11 of 11 declarations
